Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
May 16, 2023 |
returned to senate passed assembly ordered to third reading cal.175 substituted for a5653b returned to assembly repassed senate |
May 08, 2023 |
amended on third reading 608c |
Apr 24, 2023 |
amended on third reading 608b |
Apr 24, 2023 |
vote reconsidered - restored to third reading returned to senate recalled from assembly |
Jan 17, 2023 |
referred to consumer affairs and protection delivered to assembly passed senate ordered to third reading cal.77 reported and committed to rules |
Jan 12, 2023 |
print number 608a |
Jan 12, 2023 |
amend and recommit to consumer protection |
Jan 05, 2023 |
referred to consumer protection |
Senate Bill S608A
2023-2024 Legislative Session
Sponsored By
(D, WF) 18th Senate District
Current Bill Status - Passed Senate & Assembly
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
Bill Amendments
co-Sponsors
(D, WF) 25th Senate District
(D, WF) 12th Senate District
(R, C, IP) 54th Senate District
(D, WF) 31st Senate District
2023-S608 - Details
2023-S608 - Sponsor Memo
BILL NUMBER: S608 SPONSOR: SALAZAR TITLE OF BILL: An act to amend the general business law, in relation to the price goug- ing of medicine PURPOSE OR GENERAL IDEA OF THE BILL: This legislation adds medicine to the list of goods and services that can be classified as possibly being subject to price gouging. SUMMARY OF SPECIFIC PROVISIONS: Section 1: Section 396-rrr of the general business law is amended to add medicine to the list of consumer goods that can be classified as subject to price gouging. The classification of medicines falling under this section of law will be determined by the publicly reported drug short- ages reported by the U.S. Food and Drug Administration (FDA). Section 2: Bans the price gouging of medicines listed as been in short
2023-S608 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 608 2023-2024 Regular Sessions I N S E N A T E January 5, 2023 ___________ Introduced by Sens. SALAZAR, BRISPORT, GIANARIS, HELMING, JACKSON, KRUEGER, LANZA, SANDERS, SERRANO -- read twice and ordered printed, and when printed to be committed to the Committee on Consumer Protection AN ACT to amend the general business law, in relation to the price goug- ing of medicine THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The general business law is amended by adding a new section 396-rrr to read as follows: § 396-RRR. PRICE GOUGING OF MEDICINE. 1. FOR THE PURPOSES OF THIS SECTION, "DRUG SUBJECT TO A SHORTAGE" SHALL MEAN ANY DRUG OR MEDICAL PRODUCT INTENDED FOR HUMAN USE PUBLICLY REPORTED AS BEING SUBJECT TO A SHORTAGE BY THE U.S. FOOD AND DRUG ADMINISTRATION ON ITS WEBSITE, PROVIDED, HOWEVER, THAT A DRUG OR MEDICAL PRODUCT SHALL ONLY BE CONSID- ERED A "DRUG SUBJECT TO A SHORTAGE" DURING THE PERIOD OF TIME THAT SUCH DRUG OR MEDICAL PRODUCT IS LISTED AS BEING SUBJECT TO A SHORTAGE ON SUCH WEBSITE. 2. NO MANUFACTURER, SUPPLIER, WHOLESALER, DISTRIBUTOR OR RETAIL SELLER OF ANY DRUG SUBJECT TO A SHORTAGE SHALL SELL OR OFFER TO SELL ANY SUCH DRUG SUBJECT TO A SHORTAGE FOR AN AMOUNT WHICH REPRESENTS AN UNCONSCION- ABLY EXCESSIVE PRICE. 3. WHETHER A PRICE IS UNCONSCIONABLY EXCESSIVE IS A QUESTION OF LAW FOR THE COURT. (A) THE COURT'S DETERMINATION THAT A VIOLATION OF THIS SECTION HAS OCCURRED SHALL BE BASED ON ANY OF THE FOLLOWING FACTORS: (I) THAT THE AMOUNT OF THE EXCESS IN PRICE IS UNCONSCIONABLY EXTREME; (II) THAT THERE WAS AN EXERCISE OF UNFAIR LEVERAGE OR UNCONSCIONABLE MEANS; OR (III) A COMBINATION OF BOTH FACTORS IN SUBPARAGRAPHS (I) AND (II) OF THIS PARAGRAPH. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD03763-01-3
co-Sponsors
(D, WF) 25th Senate District
(D, WF) 12th Senate District
(R, C, IP) 54th Senate District
(D, WF) 31st Senate District
2023-S608A - Details
2023-S608A - Sponsor Memo
BILL NUMBER: S608A SPONSOR: SALAZAR TITLE OF BILL: An act to amend the general business law, in relation to the price goug- ing of medicine PURPOSE OR GENERAL IDEA OF THE BILL: This legislation adds medicine to the list of goods and services that can be classified as possibly being subject to price gouging. SUMMARY OF SPECIFIC PROVISIONS: Section 1: Amends subdivision 2 of section 396-r of the general business law to add the phrase "drug shortage" to the definition of "abnormal disruption of the market" and to further define the phrase "drug short- age" to mean the issuance of a notice by the U.S. Food and Drug Adminis- tration declaring a drug shortage. Section 2: Establishes the effective date.
2023-S608A - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 608--A 2023-2024 Regular Sessions I N S E N A T E January 5, 2023 ___________ Introduced by Sens. SALAZAR, BRISPORT, GIANARIS, HELMING, JACKSON, KRUEGER, LANZA, SANDERS, SERRANO -- read twice and ordered printed, and when printed to be committed to the Committee on Consumer Protection -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the general business law, in relation to the price goug- ing of medicine THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 2 of section 396-r of the general business law, as amended by chapter 90 of the laws of 2020, is amended to read as follows: 2. (A) During any abnormal disruption of the market for goods and services vital and necessary for the health, safety and welfare of consumers or the general public, no party within the chain of distrib- ution of such goods or services or both shall sell or offer to sell any such goods or services or both for an amount which represents an uncon- scionably excessive price. (B) For purposes of this section, the phrase "abnormal disruption of the market" shall mean any change in the market, whether actual or immi- nently threatened, resulting from stress of weather, convulsion of nature, failure or shortage of electric power or other source of energy, strike, civil disorder, war, military action, national or local emergen- cy, DRUG SHORTAGE, or other cause of an abnormal disruption of the market which results in the declaration of a state of emergency by the governor. FOR PURPOSES OF THIS SECTION, THE TERM DRUG SHORTAGE SHALL MEAN THE ISSUANCE OF A NOTICE BY THE U.S. FOOD AND DRUG ADMINISTRATION PURSUANT TO SECTION 506C-1 OF THE FEDERAL FOOD DRUGS AND COSMETICS ACT OR ANY SUCCESSOR PROVISION THEREOF. (C) For the purposes of this section, the term goods and services shall include [(a)] (I) consumer goods and services used, bought or EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD03763-03-3
co-Sponsors
(D, WF) 25th Senate District
(D, WF) 12th Senate District
(R, C, IP) 54th Senate District
(D, WF) 31st Senate District
2023-S608B - Details
2023-S608B - Sponsor Memo
BILL NUMBER: S608B SPONSOR: SALAZAR TITLE OF BILL: An act to amend the general business law, in relation to the price goug- ing of medicine PURPOSE OR GENERAL IDEA OF THE BILL: This legislation adds medicine to the list of goods and services that can be classified as possibly being subject to price gouging. SUMMARY OF SPECIFIC PROVISIONS: Section 1: Amends subdivision 2 of section 396-r of the general business law to add the phrase "drug shortage" to the definition of "abnormal disruption of the market" and to further define the phrase "drug short- age" to mean the issuance Of a notice by the U.S. Food and Drug Adminis- tration declaring a drug shortage. Section 2: Establishes the effective date.
2023-S608B - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 608--B Cal. No. 77 2023-2024 Regular Sessions I N S E N A T E January 5, 2023 ___________ Introduced by Sens. SALAZAR, BRISPORT, GIANARIS, HELMING, JACKSON, KRUEGER, LANZA, LIU, SANDERS, SERRANO -- read twice and ordered print- ed, and when printed to be committed to the Committee on Consumer Protection -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- reported favorably from said committee and committed to the Committee on Rules -- reported favorably from said committee, ordered to a third reading, passed by Senate and delivered to the Assembly, recalled, vote reconsidered, restored to third reading, amended and ordered reprinted, retaining its place in the order of third reading AN ACT to amend the general business law, in relation to the price goug- ing of medicine THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 2 of section 396-r of the general business law, as amended by chapter 90 of the laws of 2020, is amended to read as follows: 2. (A) During any abnormal disruption of the market for goods and services vital and necessary for the health, safety and welfare of consumers or the general public, no party within the chain of distrib- ution of such goods or services or both shall sell or offer to sell any such goods or services or both for an amount which represents an uncon- scionably excessive price. (B) For purposes of this section, the phrase "abnormal disruption of the market" shall mean any change in the market, whether actual or immi- nently threatened, resulting from stress of weather, convulsion of nature, failure or shortage of electric power or other source of energy, strike, civil disorder, war, military action, national or local emergen- cy, DRUG SHORTAGE, or other cause of an abnormal disruption of the market which results in the declaration of a state of emergency by the governor. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
co-Sponsors
(D, WF) 25th Senate District
(D, WF) 12th Senate District
(R, C, IP) 54th Senate District
(D, WF) 31st Senate District
2023-S608C (ACTIVE) - Details
2023-S608C (ACTIVE) - Sponsor Memo
BILL NUMBER: S608C SPONSOR: SALAZAR TITLE OF BILL: An act to amend the general business law, in relation to the price goug- ing of medicine PURPOSE OR GENERAL IDEA OF THE BILL: This legislation adds medicine to the list of goods and services that can be classified as possibly being subject to price gouging. SUMMARY OF SPECIFIC PROVISIONS: Section 1: Amends subdivision 2 of section 396-r of the general business law to add the phrase "drug shortage" to the definition of "abnormal disruption of the market" and to further define the phrase "drug short- age" to mean the issuance of a notice by the U.S. Food and Drug Adminis- tration declaring a drug shortage. Section 2: Establishes the effective date.
2023-S608C (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 608--C Cal. No. 77 2023-2024 Regular Sessions I N S E N A T E January 5, 2023 ___________ Introduced by Sens. SALAZAR, BRISPORT, GIANARIS, HELMING, JACKSON, KRUEGER, LANZA, LIU, SANDERS, SERRANO -- read twice and ordered print- ed, and when printed to be committed to the Committee on Consumer Protection -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- reported favorably from said committee and committed to the Committee on Rules -- reported favorably from said committee, ordered to a third reading, passed by Senate and delivered to the Assembly, recalled, vote reconsidered, restored to third reading, amended and ordered reprinted, retaining its place in the order of third reading -- again amended and ordered reprinted, retaining its place in the order of third reading AN ACT to amend the general business law, in relation to the price goug- ing of medicine THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 2 of section 396-r of the general business law, as amended by chapter 90 of the laws of 2020, is amended to read as follows: 2. (A) During any abnormal disruption of the market for goods and services vital and necessary for the health, safety and welfare of consumers or the general public, no party within the chain of distrib- ution of such goods or services or both shall sell or offer to sell any such goods or services or both for an amount which represents an uncon- scionably excessive price. (B) For purposes of this section, the phrase "abnormal disruption of the market" shall mean any change in the market, whether actual or immi- nently threatened, resulting from stress of weather, convulsion of nature, failure or shortage of electric power or other source of energy, strike, civil disorder, war, military action, national or local emergen- cy, DRUG SHORTAGE, or other cause of an abnormal disruption of the EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD03763-10-3
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.